Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro

Fundamental and Applied Toxicology

Volumn 30, Issue 1, 1996, Pages 93-101

  Connor, K ^a   Howell, J ^a   Chen, I ^a   Liu, H ^a   Berhane, K ^b   Sciarretta, C ^b   Safe, S ^a   Zacharewski, T ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATRAZINE; ESTROGEN RECEPTOR; LUCIFERASE; PROGESTERONE RECEPTOR; SIMAZINE;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER CELL; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; ESTROGEN ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; RAT; UTERUS; YEAST;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 26844457234     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0046     Document Type: Article

References (38)

1. Anazano, M. A., Smith, J. M., Uskokovic, M. R., Peer, C. W., Mullen, L. T., Letterio, J. J., Welsh, M. C., Brown, C. C., Roberts, A. B., and Sporn, M. B. (1994). 1α,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro 24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Cancer Res. 54, 1653-1656.
2. Berry, M., Metzger, D., and Chambon, P. (1990). Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonist activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9, 2811-2818.
3. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantties of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
4. Brasier, A. R., Tate, J. E., and Habener, J. F. (1989). Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques 7, 1116-1122.
5. Carver, L. A., Jackiw, V., and Bradfield, C. A. (1994). The 90-kDa heat shock protein is essential for Ah receptor signaling in a yeast expression system. J. Biol. Chem. 265, 30109-30112.
6. Demirpence, E., Balaguer, P., Trousse, F., Nicolas, J. C., Pons, M., and Gagne, D. (1994). Antiestrogenic affects of retinoic acid and 1,25-dihydroxyvitamin D3 in human breast cancer cells occur at the estrogen response element but through different molecular mechanisms. Cancer Res. 54, 1458-1464.
7. Dickerson, R., and Safe, S. (1992). The effects of 6-nitro-1,3,8-trichlorodibenzofuran as a partial estrogen in the female rat. Toxicol. Appl. Pharmacol. 113, 55-63.
8. Dix, C. J., and Jordan, V. C. (1980). Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen. Endocrinology 107, 2011-2016.
9. Eldridge, J. C., Fleenor-Heyser, D. G., Extrom, P. C., Wetzel, L. T., Breckenridge, C. B., Gillis, J. H., Luempert, L. G., and Stevens, J. T. (1994). Short-term effects of chlorotriazines on estrus in female Sprague-Dawley and Fischer-344 rats. J. Toxicol. Environ. Health 43, 155-167.
10. Fontana, J. A., Miranda, D., and Mezu, A. B. (1990). Retinoic acid inhibition of human breast cancer carcinoma proliferation is accompanied by inhibition of the synthesis of a Mr 39,000 protein. Cancer Res. 50, 1977-1982.
11. Harper, N., Wang, X., Liu, H., and Safe, S. (1994). Inhibition of estrogen-induced progesterone receptor in MCF-7 human breast cancer cells by aryl hydrocarbon (Ah) receptor agonists. Mol. Cell. Endocrinol. 104, 47-55.
12. Heery, D. M., Zacharewski, T., Pierrat, B., Gronemeyer, H., and Chambon, P. (1993). Efficient transactivation by retinoic acid receptors in yeast requires retinoid X receptors. Proc. Natl. Acad. Sci. USA 90, 4281-4285.
13. Horwitz, K. B., and McGuire, W. L. (1978). Estrogen control of progesterone receptors in human breast cancer. J. Biol. Chem. 255, 2223-2228.
14. Kastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., and Chambon, P. (1990). Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9, 1603-1614.
15. Keller, H., Givel, F., Perroud, M., and Wahli, W. (1995). Signaling crosstalk between peroxisome proliferator activated receptor/retinoid X receptor through estrogen response elements. Mol. Endo. 9, 794-804.
16. Lamb, D. J., and Bullock, D. W. (1983). Hydrophobic interaction chromatography of the rabbit uterine progesterone receptor. J. Steroid Biochem. 19, 1039-1045.
17. Lyttle, C. R., and DeSombre, E. R. (1977). Uterine peroxidase activity as a marker for estrogen action. Proc. Natl. Acad. Sci. USA 74, 3162-3166.
18. Mak, P., McDonnell, D. P., Weigel, N., Schrader, W. T., and O'Malley, B. (1989). Expression of functional chicken oviduct progesterone receptors in yeast (Saccharomyces cerevisiae). J. Biol. Chem. 264, 21613-21618.
19. McDonnell, D. P., Pike, W., Drutz, D. J., Butt, T. R., and O'Malley, B. W. (1989). Reconstitution of the vitamin D-responsive osteocalcin transcription unit in Saccharomyces cerevisiae. Mol. Cell. Biol. 9, 3517-3523.
20. Metzger, D., White, J., and Chambon, P. (1988). The human estrogen receptor functions in yeast. Nature 334, 31-35.
21. Ohashi, H., Yang, Y.-F., and Wafish, P. G. (1991). Rat liver c-erb A β1 thyroid receptor is a constitutive activator in yeast (Saccharomyces cerevisiae): Essential role for domains D, E and F in hormone-independent transcription. Biochem. Biophys. Res. Commun. 178, 1167-1175.
22. Pierrat, B., Heery, D., Lemoine, Y., and Losson, R. (1992). Functional analysis of the human estrogen receptor using a phenotypic transactivation assay in yeast. Gene 119, 237-245.
23. Purvis, I. J., Chotai, D., Dykes, C. W., Lubahn, D. B., French, F. S., Wilson, E. M., and Hobden, A. N. (1991). An androgen-inducible expression system for Saccharomyces cerevisiae. Gene 106, 35-42.
24. Rose, M. D., Winston, F., and Hieter, P. (1990). Methods in Yeast Genetics A Laboratory Course Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
25. Rubin, M., Fenig, E., Rosenauer, A., Menendez-Botet, C., Achkar, C., Bentel, J. M., Yahalom, J., Mendelsohn, J., and Miller, W. H. (1994). 9-cis retinoic acid inhibits growth of human breast cancer cells and down-regulates estrogen receptor RNA and protein. Cancer Res. 54, 6549-6556.
26. Safe, S., Harris, M., Biegel, L., and Zacharewski, T. (1991). Mechanism of action of TCDD as an antiestrogen in transformed human breast cancer and rodent cell lines Banbury Rep. 35, 367-377.
27. Sambrook, J., Fristch, E. F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
28. Santen, R. J., Manni, A., Harvey, H., and Redmond, C. (1990). Endocrine treatment of breast cancer in women. Endo. Rev. 11, 221-265.
29. Segars, J. H., Marks, M. S., Hirschfeld, S., Driggers, P. H., Martinez, E., Grippo, J. F., Wahli, W., and Ozato, K. (1993). Inhibition of estrogenresponsive gene activation by the retinoid X receptor β: Evidence for multiple inhibitory pathways Mol. Cell. Biol. 13, 2258-2269.
30. Stevens, J. T., Breckenridge, C. B., Wetzel, L. T., Gillis, J. H., Luempert, L. G., III, and Elderidge, J. C. (1994). Hypothesis for mammary tumorgenesis in Sprague-Dawley rats exposed to certain triazine herbicides. J. Toxicol. Environ. Health 43, 183-186.
31. Tennant, M. K., Hill, D. S., Elderidge, J. C., Wetzel, L. T., Breckenridge, C. B., and Stevens, J. T. (1994a). Anti-estrogenic properties of chloroS-triazinesin rat uterus J. Toxicol. Environ. Health 43, 183-186.
32. Tennant, M. K., Hill, D. S., Elderidge, J. C., Wetzel, L. T., Breckenridge, C. B., and Sevens, J. T. (1994b). Chloro-S-triazine antagonism of estrogen action: Limited interaction with estrogen receptor binding. J. Toxicol. Environ. Health 43, 197-211.
33. Tora, L., White, J., Brou, C., Tasset, D., Webster, N., Scheer, E., and Chambon, P. (1989). The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59, 477-487.
34. Turcotte, B., Meyer, M.-E., Bellard, M., Dretzen, G., Gronemeyer, H., and Chambon, P. (1991). Control of transcription of the chicken progesterone receptor gene. In vitro and in vivo studies. J. Biol. Chem. 266, 2582-2589.
35. Wang, X., Porter, W., Krishnan, V., Narasimhan, T. R., and Safe, S. (1993). Mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated decrease of the nuclear estrogen receptor in MCF-7 human breast cancer cells. Mol. Cell. Endocrinol. 96, 159-166.
36. Webster, N. J. G., Green, S., Tasset, D., Ponglikitmongkol, M., and Chambon, P. (1989). The transcriptional activation function located in the hormone-binding domain of the human oestrogen receptor is not encoded in a single exon. EMBO J. 8, 1441-1446.
37. Wetzel, L. T., Luempert, L. G., Breckenridge, C. B., Tisdel, M. O., Stevens, J. T., Thakur, A. J., Extrom, P. C., and Elderidge, J. C. (1994). Chronic effects of atrazine on estrus and mammary formation in female Sprague-Dawley and Fischer 344 rats. J. Toxicol. Environ. Health 43, 169-182.
38. Zacharewski, T., Berhane, K., Gillesby, B., and Burnison, K. (1995). Detection of estrogen- and dioxin-like activity in pulp and paper mill black liquor effluent using in vitro recombinant receptor/reporter gene assays. Environ. Sci. Tech. 29, 2140-2146.